MASCC Risk Index for Febrile Neutropenia
Identifies patients at low risk for poor outcome with febrile neutropenia.
INSTRUCTIONS
Use in neutropenic patients (see ANC calculator) with fever at least 100.4°F (38ºC). Do not use in patients with acute leukemia undergoing induction chemotherapy or allogeneic hematopoietic stem cell transplant conditioning, per IDSA guidelines.
Result:
Please fill out required fields.
Dr. Jean Klastersky
About the creator
Jean Klastersky, MD, is a professor of medicine at the University of Brussels. He is also currently the chief of medicine services at the Institut Jules Bordet. Dr. Klastersky's research focuses on treatment and prognosis in neutropenic fever and novel therapies in cancer patients.
To view Dr. Jean Klastersky's publications, visit PubMed
Are you Dr. Jean Klastersky? Send us a message to review your photo and bio, and find out how to submit Creator Insights!
MDCalc loves calculator creators – researchers who, through intelligent and often complex methods, discover tools that describe scientific facts that can then be applied in practice. These are real scientific discoveries about the nature of the human body, which can be invaluable to physicians taking care of patients.
Content Contributors
- Justin Taylor, MD